The rise of Viagra initially sparked a period of growth for the drug industry, however recent changes present a uncertain outlook for shareholders. Generic competitors are reducing revenue, and continued litigation add https://violaunkj952013.blogerus.com/63156537/the-blue-pill-and-big-pharma-a-volatile-investment